Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 452153, 11 pages
http://dx.doi.org/10.1093/ecam/neq018
Original Article

Biphasic Effect of Curcumin on Morphine Tolerance: A Preliminary Evidence from Cytokine/Chemokine Protein Array Analysis

1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan
2Department of Anesthesiology, Taipei Medical University Hospital, Taipei Medical University, Taiwan
3Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taiwan
4Department of Anesthesiology, Anesthetics and Toxicology Research Center, Taipei Medical University Hospital, Taipei Medical University, Taiwan
5Cancer Center, Wan-Fang Hospital, Taipei Medical University, Taiwan
6Department of Anesthesiology, Cathay General Hospital, Taipei, Taiwan
7Pritzker School of Medicine, University of Chicago, IL, USA
8Department of Pediatrics, Taipei Medical University Hospital, Taipei, Taiwan

Received 22 June 2009; Accepted 8 February 2010

Copyright © 2011 Jui-An Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Foley, “Opioids,” Neurologic Clinics, vol. 11, no. 3, pp. 503–522, 1993. View at Google Scholar · View at Scopus
  2. M. R. Hutchinson, B. D. Coats, S. S. Lewis et al., “Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1178–1189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. N. Johnston, E. D. Milligan, J. Wieseler-Frank et al., “A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine,” The Journal of Neuroscience, vol. 24, pp. 7353–7365, 2004. View at Google Scholar
  4. I. Chattopadhyay, K. Biswas, U. Bandyopadhyay, and R. K. Banerjee, “Turmeric and curcumin: biological actions and medicinal applications,” Current Science, vol. 87, pp. 44–53, 2004. View at Google Scholar
  5. H. Hatcher, R. Planalp, J. Cho, F. M. Torti, and S. V. Torti, “Curcumin: from ancient medicine to current clinical trials,” Cellular and Molecular Life Sciences, vol. 65, no. 11, pp. 1631–1652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sharma, S. K. Kulkarni, J. N. Agrewala, and K. Chopra, “Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain,” European Journal of Pharmacology, vol. 536, no. 3, pp. 256–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Sharma, K. Chopra, and S. K. Kulkarni, “Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha,” Phytotherapy Research, vol. 21, no. 3, pp. 278–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Mayer, J. Mao, J. Holt, and D. D. Price, “Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions,” Proceedings of the National Academy of Sciences, vol. 96, pp. 7731–7736, 1999. View at Google Scholar
  9. J. A. Lin, R. Y. Tsai, Y. T. Lin et al., “Amitriptyline pretreatment preserves the antinociceptive effect of morphine in pertussis toxin-treated rats by lowering CSF excitatory amino acid concentrations and reversing the downregulation of glutamate transporters,” Brain Research, vol. 1232, pp. 61–69, 2008. View at Google Scholar
  10. Y. Matsushita and H. Ueda, “Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation,” NeuroReport, vol. 20, no. 1, pp. 63–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Mittal, R. Joshi, D. Hota, and A. Chakrabarti, “Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat,” Phytotherapy Research, vol. 23, no. 4, pp. 507–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. D. Lao, M. T. Ruffin IV, D. Normolle et al., “Dose escalation of a curcuminoid formulation,” BMC Complementary and Alternative Medicine, vol. 6, article 10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. E. Ali and S. I. S. Rattan, “Curcumin's biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 394–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Cole, B. Teter, and S. A. Frautschy, “Neuroprotective effects of curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 197–212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. N. Fossum, M. J. Lisowski, T. A. Macey, S. L. Ingram, and M. M. Morgan, “Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception,” Brain Research, vol. 1204, pp. 53–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-H. Pan, T.-M. Huang, and J.-K. Lin, “Biotransformation of curcumin through reduction and glucuronidation in mice,” Drug Metabolism and Disposition, vol. 27, no. 4, pp. 486–494, 1999. View at Google Scholar · View at Scopus
  17. V. O. Fuentes, W. B. Hunt, and J. Crossland, “The production of morphine tolerance and physical dependence by the oral route in the rat. A comparative study,” Psychopharmacology, vol. 59, no. 1, pp. 65–69, 1978. View at Google Scholar · View at Scopus
  18. E.-M. Jang, M.-S. Choi, U. J. Jung et al., “Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters,” Metabolism, vol. 57, no. 11, pp. 1576–1583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Anubhuti and S. Arora, “Leptin and its metabolic interactions—an update,” Diabetes, Obesity and Metabolism, vol. 10, no. 11, pp. 973–993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. T. Montague, I. S. Farooqi, J. P. Whitehead et al., “Congenital leptin deficiency is associated with severe early-onset obesity in humans,” Nature, vol. 387, no. 6636, pp. 903–908, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ejaz, D. Wu, P. Kwan, and M. Meydani, “Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice,” Journal of Nutrition, vol. 139, no. 5, pp. 919–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Tam, D. G. Duda, J. Y. Perentes, R. S. Quadri, D. Fukumura, and R. K. Jain, “Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells,” PLoS ONE, vol. 4, no. 3, Article ID e4974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. H. R. Lijnen, V. Christiaens, I. Scroyen et al., “Impaired adipose tissue development in mice with inactivation of placental growth factor function,” Diabetes, vol. 55, no. 10, pp. 2698–2704, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Li, E. E. Sharpe, A. B. Maupin et al., “VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization,” The FASEB Journal, vol. 20, no. 9, pp. 1495–1497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Hu, C. Fan, C. Livasy et al., “A compact VEGF signature associated with distant metastases and poor outcomes,” BMC Medicine, vol. 7, article no. 9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Roy, S. Balasubramanian, J. Wang, Y. Chandrashekhar, R. Charboneau, and R. Barke, “Morphine inhibits VEGF expression in myocardial ischemia,” Surgery, vol. 134, no. 2, pp. 336–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Sasamura, S. Nakamura, Y. Iida et al., “Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation,” European Journal of Pharmacology, vol. 441, no. 3, pp. 185–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. Z.-H. Wen, G.-J. Wu, Y.-C. Chang, J.-J. Wang, and C.-S. Wong, “Dexamethasone modulates the development of morphine tolerance and expression of glutamate transporters in rats,” Neuroscience, vol. 133, no. 3, pp. 807–817, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Z.-H. Wen, Y.-C. Chang, C.-H. Cherng, J.-J. Wang, P.-L. Tao, and C.-S. Wong, “Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats,” Brain Research, vol. 995, no. 2, pp. 253–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-H. Tai, Y.-H. Wang, J.-J. Wang, P.-L. Tao, C.-S. Tung, and C.-S. Wong, “Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats,” Pain, vol. 124, no. 1-2, pp. 77–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. H. Jhamandas, M. Marsala, T. Ibuki, and T. L. Yaksh, “Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine,” Journal of Neuroscience, vol. 16, no. 8, pp. 2758–2766, 1996. View at Google Scholar · View at Scopus
  32. J. Mao, B. Sung, R.-R. Ji, and G. Lim, “Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism,” Journal of Neuroscience, vol. 22, no. 17, pp. 7650–7661, 2002. View at Google Scholar · View at Scopus
  33. O. Meucci, A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, and R. J. Miller, “Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14500–14505, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Minami, K. Yamamoto, H. Kiyoi, R. Ueda, H. Saito, and T. Naoe, “Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia,” Blood, vol. 102, pp. 2969–2975, 2003. View at Google Scholar
  35. C. Y. Brazel, M. H. Ducceschi, B. Pytowski, and S. W. Levison, “The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival,” Molecular and Cellular Neuroscience, vol. 18, no. 4, pp. 381–393, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Yamasaki, T. Setoguchi, T. Takenouchi, K. Yone, and S. Komiya, “Stem cell factor prevents neuronal cell apoptosis after acute spinal cord injury,” Spine, vol. 34, pp. 323–327, 2009. View at Google Scholar
  37. K. M. Dhandapani, F. M. Wade, C. Wakade, V. B. Mahesh, and D. W. Brann, “Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFκB,” Journal of Neurochemistry, vol. 95, no. 1, pp. 9–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. D. E. Brenneman, J. Hauser, C. Y. Spong, T. M. Phillips, C. B. Pert, and M. Ruff, “VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death,” Brain Research, vol. 838, no. 1-2, pp. 27–36, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Relić, J. Guicheux, F. Mezin et al., “IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis,” The Journal of Immunology, vol. 166, no. 4, pp. 2775–2782, 2001. View at Google Scholar · View at Scopus
  40. G. K. Singhera, R. MacRedmond, and D. R. Dorscheid, “Interleukin-9 and -13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells,” Experimental Lung Research, vol. 34, no. 9, pp. 579–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Ke, X.-D. Shen, C. R. Lassman, F. Gao, R. W. Busuttil, and J. W. Kupiec-Weglinski, “Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent,” American Journal of Transplantation, vol. 3, no. 9, pp. 1076–1082, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo, “The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5856–5861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. W. H. Shin, D.-Y. Lee, K. W. Park et al., “Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo,” GLIA, vol. 46, no. 2, pp. 142–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. P. C. Charles, X. Chen, M. S. Horwitz, and C. F. Brosnan, “Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice,” Journal of NeuroVirology, vol. 5, no. 1, pp. 55–64, 1999. View at Google Scholar · View at Scopus
  45. D. Bauer, S. Wasmuth, M. Hennig, H. Baehler, K. P. Steuhl, and A. Heiligenhaus, “Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis,” Investigative ophthalmology & visual science, vol. 50, no. 7, pp. 3188–3198, 2009. View at Google Scholar · View at Scopus
  46. P. C.-H. Chen, G. C. DuBois, and M.-J. Chen, “Mapping the domain(s) critical for the binding of human tumor necrosis factor-α to its two receptors,” The Journal of Biological Chemistry, vol. 270, no. 6, pp. 2874–2878, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Engelmann, D. Novick, and D. Wallach, “Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors,” Journal of Biological Chemistry, vol. 265, no. 3, pp. 1531–1536, 1990. View at Google Scholar · View at Scopus
  48. K. K. Hale, C. G. Smith, S. L. Baker et al., “Multifunctional regulation of the biological effects of TNF-α by the soluble type I and type II TNF receptors,” Cytokine, vol. 7, no. 1, pp. 26–38, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. M. F. Shamji, L. Jing, J. Chen et al., “Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier,” Journal of Neurosurgery: Spine, vol. 9, no. 2, pp. 221–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. C. J. Nelson, L. A. Dykstra, and D. T. Lysle, “Comparison of the time course of Morphine's analgesic and immunologic effects,” Anesthesia and Analgesia, vol. 85, no. 3, pp. 620–626, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. T. K. Eisenstein, R. T. Rahim, P. Feng, N. K. Thingalaya, and J. J. Meissler, “Effects of opioid tolerance and withdrawal on the immune system,” Journal of Neuroimmune Pharmacology, vol. 1, no. 3, pp. 237–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. R. T. Rahim, P. Feng, J. J. Meissler Jr. et al., “Paradoxes of immunosuppression in mouse models of withdrawal,” Journal of Neuroimmunology, vol. 147, no. 1-2, pp. 114–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. L. M. Bohn, R. R. Gainetdinov, F.-T. Lin, R. J. Lefkowitz, and M. G. Caron, “μ-opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence,” Nature, vol. 408, no. 6813, pp. 720–723, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Salvioli, E. Sikora, E. L. Cooper, and C. Franceschi, “Curcumin in cell death processes: a challenge for CAM of age-related pathologies,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 2, pp. 181–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. R.-P. Huang, R. Huang, Y. Fan, and Y. Lin, “Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system,” Analytical Biochemistry, vol. 294, no. 1, pp. 55–62, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Dohare, P. Garg, V. Jain, C. Nath, and M. Ray, “Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat,” Behavioural Brain Research, vol. 193, no. 2, pp. 289–297, 2008. View at Publisher · View at Google Scholar · View at Scopus